Jan 14, 2026

Featuring perspectives from Prof Giuseppe Curigliano, Prof Nadia Harbeck, Dr Ian E Krop, Dr Nancy U Lin and Dr Joyce O’Shaughnessy, including the following topics: 

• Introduction (0:00)
• Considerations in the Care of Patients with Localized HER2-Positive Breast Cancer — Prof Harbeck (1:39)
• Case: A woman in her mid...

Jan 8, 2026

Featuring perspectives from Dr Javier Cortés, Dr Rita Nanda, Prof Peter Schmid and Dr Priyanka Sharma, including the following topics: 

• Introduction (0:00)
• Case: A woman in her early 80s with multiple comorbidities and triple-negative breast cancer (TNBC) develops bone-only metastases 4 months after declining...

Dec 23, 2025

Featuring perspectives from Dr Lisa A Carey and Dr Rita Nanda, including the following topics: 

• Overview: Molecular basis of antibody-drug conjugate (ADC) toxicities — Sequencing of ADCs and mechanisms of resistance (0:00)
• Case: A woman in her late 60s with localized triple-negative breast cancer develops...

Dec 8, 2025

Featuring perspectives from Prof Giuseppe Curigliano and Dr Priyanka Sharma, including the following topics:

• HER2-Positive Breast Cancer (0:00)
• Hormone Receptor-Positive Breast Cancer (18:16)
• Triple-Negative Breast Cancer (1:05:23)

CME information and select...

Dec 5, 2025

Featuring an interview with Dr Priyanka Sharma, including the following topics:

• Endocrine therapy for hormone receptor-positive, HER2-negative high-risk localized breast cancer (0:00)
  • Johnston SR et al. monarchE: Primary overall survival (OS) results of adjuvant abemaciclib + endocrine therapy (ET) for HR+, HER2-,...